|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444.
2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li MX, Liu XM, Zhang XF, Zhang JF, Wang
WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L and Lv Y: Prognostic role
of neutrophil-to-lymphocyte ratio in colorectal cancer: A
systematic review and meta-analysis. Int J Cancer. 134:2403–2413.
2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pistelli M, De Lisa M, Ballatore Z,
Caramanti M, Pagliacci A, Battelli N, Ridolfi F, Santoni M,
Maccaroni E, Bracci R, et al: Pre-treatment neutrophil to
lymphocyte ratio may be a useful tool in predicting survival in
early triple negative breast cancer patients. BMC Cancer.
15(195)2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Nomelini RS, Carrijo Chiovato AF,
Abdulmassih FBF, da Silva RC, Tavares-Murta BM and Murta EFC:
Neutrophil-to-lymphocyte ratio and platelet count as prognostic
factors in ovarian malignancies. J Cancer Res Ther. 15:1226–1230.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Aizawa M, Gotohda N, Takahashi S, Konishi
M and Kinoshita T: Predictive value of baseline
neutrophil/lymphocyte ratio for T4 disease in wall-penetrating
gastric cancer. World J Surg. 35:2717–2722. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dirican A, Kucukzeybek Y, Somali I, Erten
C, Demir L, Can A, Bahriye Payzin K, Vedat Bayoglu I, Akyol M,
Koseoglu M, et al: The association of hematologic parameters on the
prognosis of patients with metastatic renal cell carcinoma. J BUON.
18:413–419. 2013.PubMed/NCBI
|
|
8
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: Preoperative neutrophil-lymphocyte ratio can significantly
predict mortality outcomes in patients with non-muscle invasive
bladder cancer undergoing transurethral resection of bladder tumor.
Oncotarget. 8:12891–12901. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tsai PL, Su WJ, Leung WH, Lai CT and Liu
CK: Neutrophil-lymphocyte ratio and CEA level as prognostic and
predictive factors in colorectal cancer: A systematic review and
meta-analysis. J Cancer Res Ther. 12:582–589. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kishi Y, Kopetz S, Chun YS, Palavecino M,
Abdalla EK and Vauthey JN: Blood neutrophil-to-lymphocyte ratio
predicts survival in patients with colorectal liver metastases
treated with systemic chemotherapy. Ann Surg Oncol. 16:614–622.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng
C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, et al: Cytokine
profile and prognostic significance of high neutrophil-lymphocyte
ratio in colorectal cancer. Br J Cancer. 112:1088–1097.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Malietzis G, Giacometti M, Kennedy RH,
Athanasiou T, Aziz O and Jenkins JT: The emerging role of
neutrophil to lymphocyte ratio in determining colorectal cancer
treatment outcomes: A systematic review and meta-analysis. Ann Surg
Oncol. 21:3938–3946. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transplant. 48:452–458. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lee DY, Hong SW, Chang YG, Lee WY and Lee
B: Clinical significance of preoperative inflammatory parameters in
gastric cancer patients. J Gastric Cancer. 13:111–116.
2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nagasaki T, Akiyoshi T, Fujimoto Y,
Konishi T, Nagayama S, Fukunaga Y and Ueno M: Prognostic impact of
neutrophil-to-lymphocyte ratio in patients with advanced low rectal
cancer treated with preoperative chemoradiotherapy. Dig Surg.
32:496–503. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899.
2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to virchow? Lancet. 357:539–545. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bozkurt O, Firat ST, Dogan E, Cosar R,
Inanc M and Ozkan M: The prognostic value of the change in
neutrophil-to-lymphocyte ratio during first-line palliative
chemotherapy in patients with metastatic gastric cancer: A
retrospective study. J BUON. 24:1992–1999. 2019.PubMed/NCBI
|
|
20
|
Guo D, Han A, Jing W, Chen D, Jin F, Li M,
Kong L and Yu J: Preoperative to postoperative change in
neutrophil-to-lymphocyte ratio predict survival in colorectal
cancer patients. Future Oncol. 14:1187–1196. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cui M, Xu R and Yan B: A persistent high
neutrophil-to-lymphocyte ratio predicts poor prognosis in patients
with colorectal cancer undergoing resection. Mol Clin Oncol.
13(63)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Formica V, Luccchetti J, Cunningham D,
Smyth EC, Ferroni P, Nardecchia A, Tesauro M, Cereda V, Guadagni F
and Roselli M: Systemic inflammation, as measured by the
neutrophil/lymphocyte ratio, may have differential prognostic
impact before and during treatment with fluorouracil, irinotecan
and bevacizumab in metastatic colorectal cancer patients. Med
Oncol. 31(166)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matsuda A, Yamada T, Matsumoto S,
Sakurazawa N, Kawano Y, Shinozuka E, Sekiguchi K, Suzuki H and
Yoshida H: Pretreatment neutrophil-to-lymphocyte ratio predicts
survival after TAS-102 treatment of patients with metastatic
colorectal cancer. Anticancer Res. 39:4343–4350. 2019.PubMed/NCBI View Article : Google Scholar
|
